Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
In this role, the VP, Commercial & Corporate Counsel serves as counsel to the commercial organization and leads the corporate, contracts, and employment functions of the legal department. The VP, Commercial & Corporate Counsel provides legal guidance on a wide range of commercialization issues as Dyne scales and prepares for the anticipated launches of its first therapies. These topics include advertising and promotion, compliance with FDA regulations, health care fraud and abuse laws, Value & Access matters, patient support programs, data privacy, and various federal and state laws governing the pharmaceutical industry. The VP, Commercial & Corporate Counsel also leads and manages corporate governance and public filing matters, contracting, and employment matters.
This role is based in Waltham, MA
Primary Responsibilities:
- Serve as counsel for Dyne’s commercial organization.
- Advise on global pricing, value & access strategies, contracting, trade and distribution matters, and patient access programs.
- Assess legal risk related to federal and state laws including the Anti-Kickback Statute, False Claims Act, FDA promotional regulations, antitrust, privacy, and pricing transparency laws. Propose practical, compliant solutions aligned with business strategies.
- Lead and manage the corporate, contracting, and employment legal functions for Dyne including:
- Oversee and lead the drafting, review, and filing of SEC disclosures, including Forms 10-K, 10-Q, 8-K, and proxy statements. Ensure compliance with the Securities Exchange Act of 1934, Regulation FD, and relevant stock exchange rules. Support insider trading policy administration and public disclosure processes.
- Oversee and lead legal support for Board of Directors and committee meetings; oversee management of governance documents and corporate records; oversee legal aspects of the annual stockholder meeting and proxy development; advise on governance best practices.
- Advise on corporate transactions including partnerships, mergers, acquisitions, and financings.
- Business Partnership & Leadership within the Legal team
- Provide mentorship and leadership to members of the Legal team.
- Serve as a proactive and collaborative partner with key functions including Commercial, Finance, Medical and Human Resources.
- Represent Legal on cross-functional project and governance teams to support launch readiness and commercial objectives.
- Support the Head of Legal and help mature Dyne’s commercial, corporate, contracting and employment capabilities
- Identify opportunities for process improvement and proactive legal risk management.
Education, Knowledge & Skill Requirements:
- JD from an accredited Law School; licensed to practice in at least one U.S. jurisdiction.
- 15+ years of global commercial and health care law ideally within a commercial stage global biotechnology company and a top-tier law firm
- Deep expertise in FDA regulations, U.S. health care laws, and federal health care programs; rare disease; product launches; familiarity with ex-U.S. frameworks.
- Strong understanding of PhRMA Code, Anti-Kickback Statute, False Claims Act, data privacy & security, and transparency laws.
- Demonstrated content review committee experience in the pharmaceutical industry.
- Experience advising on securities regulation, including securities law reporting, compliance and disclosure issues, shareholder meeting matters, stock exchange listing requirements, corporate governance, board matters, and executive and equity compensation
- Experience leading corporate transactions
- Proven success advising cross-functional teams (Commercial, Finance, Medical, Human Resources) on complex, time-sensitive matters.
- Skilled at balancing strategic legal guidance with practical business judgment in fast-paced, evolving environments.
- Exceptional communication, analytical, and project management skills with attention to detail and execution excellence.
- Collaborative leadership style and enterprise mindset that reinforces organizational culture and values.
- Experience thriving in a small, rapidly growing biotech or start-up environment with a solutions-oriented approach.
The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.
The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.
Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Top Skills
Dyne Therapeutics Waltham, Massachusetts, USA Office
1560 Trapelo Rd, Waltham, MA, United States, 02451
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
